Proteon Therapeutics, Inc.
BioTech/Drugs - Waltham, MA, US
Proteon Therapeutics, Inc. Employees
Proteon Therapeutics, Inc. Senior Management
Proteon Therapeutics, Inc. Details
Proteon Therapeutics is a biopharmaceutical company developing novel, first-in-class pharmaceuticals for patients with renal and vascular diseases. The Company's ongoing Phase 3 clinical trial is evaluating whether a single treatment of PRT-201 can reduce vascular access failure, one of the most serious problems experienced by patients with chronic kidney disease (CKD) undergoing hemodialysis. PRT-201 is an investigational drug that may inhibit neointimal hyperplasia, the growth of tissue inside blood vessels that can result in vessel narrowing and reduced blood flow. PRT-201 has received fast track and orphan drug designations for hemodialysis vascular access indications.
Proteon Therapeutics, Inc. Technologies
CMS
Drupal
SSL Certificates
Media Temple SSL